Tag Archives: Avrobio Inc

Avrobio Inc (AVRO) Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Avrobio Inc (AVRO – Research Report) yesterday. The company’s shares closed on Friday at $19.24. According to TipRanks.com, Baral is a 5-star analyst with an average return of 22.4%

Mizuho Securities Sticks to Its Buy Rating for Avrobio Inc (AVRO)

Mizuho Securities analyst Difei Yang reiterated a Buy rating on Avrobio Inc (AVRO – Research Report) on August 9 and set a price target of $28. The company’s shares closed on Friday at $19.24. According to TipRanks.com, Yang is a

H.C. Wainwright Maintains a Buy Rating on Avrobio Inc (AVRO)

H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating on Avrobio Inc (AVRO – Research Report) today and set a price target of $35. The company’s shares closed yesterday at $20.04. According to TipRanks.com, Chattopadhyay has 0 stars on 0-5

Avrobio Inc (AVRO) Receives a Rating Update from a Top Analyst

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Avrobio Inc (AVRO – Research Report) yesterday. The company’s shares closed yesterday at $19.16. According to TipRanks.com, Baral is a top 100 analyst with an average return of 27.3%

Cowen & Co. Maintains a Buy Rating on Avrobio Inc (AVRO)

In a report released yesterday, Ritu Baral from Cowen & Co. maintained a Buy rating on Avrobio Inc (AVRO – Research Report). The company’s shares closed yesterday at $18.53, close to its 52-week low of $11.85. According to TipRanks.com, Baral

Analysts Offer Insights on Healthcare Companies: Avrobio Inc (NASDAQ: AVRO) and Pluristem (NASDAQ: PSTI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avrobio Inc (AVRO – Research Report) and Pluristem (PSTI – Research Report) with bullish sentiments. Avrobio Inc (AVRO) In a report released